Genmab — Juni 2019
-
Nature Reviews Clinical Oncology https://www.nature.com/articles/s41571-019-0244-y https://sci-hub.tw/https://www.nature.com/articles/s41571-019-0244-y
-
-
Durie starts a bit slow, but very interesting further on with Dr. Joseph Mikhael + Dr. Philippe Moreau https://www.myeloma.org/videos/frontline-therapy-imwg-amsterdam-2019
-
hvad forventer vi i morgen, alt over 150 mio er vel fint?
-
Relapse Therapies also interesting , a bit on Isa and Dara https://www.myeloma.org/videos/relapse-therapies-imwg-amsterdam-2019
-
“With Dara coming earlier…. Where Isa is gonna fit is a little bit chalenging , because, to be honest, almost everybody will have had Daratumumab, if not in frontline then first relapse. And we dont really know how effective Isa is once you failed Dara.”
-
Investtech-analysevideo fra i går: https://play.borsen.dk/klip/5d073ad3595ab4f00a333654
-
another example of off-label? https://twitter.com/SchutzNatalia/status/1140976374464831488
-
Ser ud til det bliver en okay dag i dag..:-)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind